Brazil Developing Triple-Combination Antiretroviral Drug

Main Category: HIV / AIDS
Article Date: 24 Dec 2007 - 12:00 PDT


Brazil is in the final stages of testing a triple-combination antiretroviral drug, Orival Silveira, coordinator of the treatment and assistance unit at the Ministry of Health's National Sexually Transmitted Diseases/AIDS Program, said Wednesday, Xinhuanet reports. The three drugs used in the treatment -- zidovudine, lamivudine and nevirapine -- are being developed by the Brazil-based Oswaldo Cruz Foundation.

The triple-combination therapy will make it easier for HIV-positive people to adhere to their treatment regimens, Silveira said, adding that studies have shown that treatment regimens with more than two pills daily are more difficult for people to follow. According to the health ministry, about 180,000 people in Brazil are undergoing antiretroviral treatment, which is subsidized fully by the government (Xinhuanet, 12/20).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

• Additional
• References
• Citations